|
Report No. : |
320669 |
|
Report Date : |
06.05.2015 |
IDENTIFICATION DETAILS
|
Name : |
TRANSO-PHARM HANDELS-GMBH |
|
|
|
|
Registered Office : |
Bültbek 5 D 22962 Siek |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
29.10.1987 |
|
|
|
|
Com. Reg. No.: |
HRB 4750 AH |
|
|
|
|
Legal Form : |
Private limited company |
|
|
|
|
Line of Business : |
·
Non-specialized wholesale of raw
materials and half-finished and
finished goods |
|
|
|
|
No. of Employee : |
31 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made on
e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.3% in 2014. The new German government introduced a minimum wage of about $11.60 (8.50 euros) per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. The budget was essentially in balance in 2014. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany plans to replace nuclear power with renewable energy, which accounts for 34% of total energy consumption, up from 9% in 2000. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production.
|
Source
: CIA |
TRANSO-PHARM
HANDELS-GMBH
Company Status: active
Bültbek 5
D 22962 Siek
Telephone:04107/8778-0
Telefax: 04107/8778-100
Homepage:
www.transopharm.de
E-mail: info@transopharm.de
VAT
no.: DE118600957
Tax
ID number: 30 293 34501
Business relations are permissible.
LEGAL FORM Private limited company
Date of foundation: 29.10.1987
Shareholders'
agreement: 29.10.1987
Registered on: 17.09.2003
Commercial Register: Local court 23568 Lübeck
under: HRB
4750 AH
EUR 400,000.00
Shareholder:
Transo-Pharm Holding-AG
Bültbek 5
D 22962 Siek
Legal form: Public
limited company
Share capital: EUR 642,000.00
Share: EUR 400,000.00
Registered on: 30.06.2003
Reg. data: 23568 Lübeck,
HRB 4716 AH
Manager:
Philipp Alexander
Titulski
D 21266 Jesteburg
born: 07.02.1963
Profession: Businessman
Marital status: single
Manager:
Frank Krause
An der Glinder Au 11 b
D 22115 Hamburg
born: 08.08.1968
Profession: Businessman
Marital status: married
Manager:
Justus Bogislav Wilhelm
Dehio
D 20095 Hamburg
born: 18.03.1977
Proxy:
Ralph Quitzau
Grote Wisch 1
D 22927 Großhansdorf
authorized to jointly
represent the company
Proxy:
Andreas Freihse
D 20095 Hamburg
authorized to jointly
represent the company
Profession: Businessman
Further functions/participations of Philipp
Alexander Titulski
(Manager)
Manager:
Chemex Hamburg GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 30,000.00
Registered
on: 24.09.2003
Reg. data: 23568 Lübeck, HRB 4753 AH
Manager:
TRANSO-PHARM
Produktions-GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 150,000.00
Registered
on: 18.08.2003
Reg. data: 23568 Lübeck, HRB 4743 AH
Manager:
OGX GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 100,000.00
Registered
on: 28.01.2010
Reg. data: 23568 Lübeck, HRB 9810 HL
Manager:
Transo-Pharm Vet-GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 100,000.00
Registered
on: 11.03.2011
Reg. data: 23568 Lübeck, HRB 10894 HL
Shareholder:
Transo-Pharm Holding-AG
Bültbek 5
D 22962 Siek
Legal form: Public
limited company
Share capital: EUR 642,000.00
Share: 48.500 %
Registered
on: 30.06.2003
Reg. data: 23568 Lübeck, HRB 4716 AH
Member of the Board of Directors:
Transo-Pharm Holding-AG
Bültbek 5
D 22962 Siek
Legal form: Public
limited company
Share capital: EUR 642,000.00
Registered
on: 30.06.2003
Reg. data: 23568 Lübeck, HRB 4716 AH
Proxy:
BiDiPharma GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 30,000.00
Registered
on: 12.01.2011
Reg. data: 23568 Lübeck, HRB 10715 HL
Further functions/participations of Frank
Krause (Manager)
Shareholder:
Ka Ro
Unternehmensberatung GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 25,564.59
Share: EUR 25,564.59
Registered
on: 08.09.1998
Reg. data: 23568 Lübeck, HRB 4049 AH
Manager:
Ka Ro
Unternehmensberatung GmbH
Bültbek 5
D 22962 Siek
Legal form:
Private limited company
Share capital: EUR 25,564.59
Registered
on: 08.09.1998
Reg. data: 23568 Lübeck, HRB 4049 AH
Proxy:
Transo-Pharm Vet-GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 100,000.00
Registered
on: 11.03.2011
Reg. data: 23568 Lübeck, HRB 10894 HL
Further functions/participations of Justus
Bogislav Wilhelm Dehio
(Manager)
Proxy:
Transo-Pharm Vet-GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Share capital: EUR 100,000.00
Registered
on: 11.03.2011
Reg. data: 23568 Lübeck, HRB 10894 HL
29.10.1987 - 07.1997 TRANSO-PHARM HANDELS-GMBH
Colonnaden 21
D 20354 Hamburg
Private limited company
08.1997 - 15.09.2003 TRANSO-PHARM HANDELS-GMBH (AG Hamburg,
HRB 47781)
Ausschläger Billdeich
50
D 20539 Hamburg
Private limited company
Sectors
46461
Wholesale of pharmaceutical goods
46750
Wholesale of chemical products
46902
Non-specialized wholesale of raw materials and
half-finished and finished goods
Shareholder:
Chemex Hamburg GmbH
Bültbek 5
D 22962 Siek
Legal form: Private
limited company
Company Status: active
Share capital: EUR 30,000.00
Share: EUR 21,000.00
Reg. data: 24.09.2003
Local court
23568 Lübeck
HRB 4753 AH
Payment experience: within agreed terms
Negative information:We have no negative
information at hand.
Balance sheet year: 2013
Type of ownership: Tenant
Address Bültbek 5
D 22962 Siek
Land register documents were not available.
Principal bank
COMMERZBANK, 20454 HAMBURG
Sort. code: 20040000, Account no.: 2265965
BIC: COBADEHHXXX, IBAN: DE61200400000226596500
Further banks
UNICREDIT BANK - HYPOVEREINSBANK, 20454
HAMBURG
Sort. code: 20030000, Account no.: 621906429
BIC: HYVEDEMM300, IBAN: DE85200300000621906429
UNICREDIT BANK - HYPOVEREINSBANK, 80311
MÜNCHEN
Sort. code: 70020270, Account no.: 878035534
BIC: HYVEDEMMXXX, IBAN: DE74700202700878035534
Turnover: 2013 EUR 17,697,765.00
Profit: 2013 EUR 994,554.00
Equipment: EUR 201,057.00
Ac/ts receivable: EUR 4,378,904.00
Liabilities: EUR 4,235,603.00
Employees:
31
-
thereof permanent staff: 12
-
Part-time employees: 14
-
Trainees:
1
-
Temporary workers: 3
Balance sheet ratios 01.01.2013 - 31.12.2013
Equity ratio [%]: 37.23
Liquidity ratio: 1.46
Return on total capital [%]: 15.44
Balance sheet ratios 01.01.2012 - 31.12.2012
Equity ratio [%]: 33.94
Liquidity ratio: 1.86
Return
on total capital [%]: 6.67
Balance sheet ratios 01.01.2011 - 31.12.2011
Equity ratio [%]: 1.55
Liquidity ratio: 0.88
Return on total capital [%]: 6.03
Equity ratio
The
equity ratio indicates the portion of the equity as compared
to
the total capital. The higher the equity ratio, the better the
economic stability (solvency) and thus the
financial autonomy of
a
company.
Liquidity ratio
The
liquidity ratio shows the proportion between adjusted
receivables and net liabilities. The higher
the ratio, the lower
the
company's financial dependancy from external creditors.
Return on total capital
The
return on total capital shows the efficiency and return on
the
total capital employed in the company. The higher the return
on
total capital, the more economically does the company work
with the invested capital.
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2013 - 31.12.2013
ASSETS EUR 6,536,876.07
Fixed assets
EUR 367,536.88
Intangible assets
EUR 33,221.50
Concessions, licences, rights
EUR 20,852.50
Other / unspecified intangible assetsEUR 12,369.00
Tangible assets
EUR 201,057.00
Other tangible assets / fixtures and
fittings
EUR 201,057.00
Financial
assets EUR 133,258.38
Shares in participations /
subsidiaries and the like
EUR 123,258.38
Shares in related companies
EUR 21,000.00
Shares in investee companies
EUR 102,258.38
Other loans
EUR 10,000.00
Current assets
EUR 6,081,448.89
Stocks
EUR 1,484,310.92
Finished goods / work in progress
EUR 1,328,610.34
Advance payments made
EUR 155,700.58
Accounts receivable
EUR 4,378,903.60
Amounts due from shareholders
EUR 90,000.00
Trade debtors EUR 3,366,379.97
Amounts due from related companies
EUR 334,199.78
Other debtors and assets
EUR 588,323.85
Liquid means
EUR 218,234.37
Remaining other assets
EUR 87,890.30
Accruals (assets)
EUR 80,710.60
Deferred taxes (assets)
EUR 7,179.70
LIABILITIES EUR 6,536,876.07
Shareholders' equity
EUR 1,415,674.91
Capital
EUR 400,000.00
Subscribed capital (share capital)
EUR 400,000.00
Balance sheet profit/loss (+/-)
EUR 1,015,674.91
Profit / loss brought forward
EUR 21,120.60
Annual surplus / annual deficit
EUR 994,554.31
Provisions
EUR 885,597.82
Pension
provisions and comparable
provisions
EUR 538,498.00
Provisions for taxes
EUR 42,077.00
Other / unspecified provisions
EUR 305,022.82
Liabilities EUR 4,235,603.34
Financial debts
EUR 71,649.96
Liabilities due to banks
EUR 71,649.96
Other liabilities
EUR 4,163,953.38
Trade creditors (for IAS incl. bills
of exchange)
EUR 3,021,194.95
Liabilities from received advance
payments
EUR 29,485.30
Liabilities due to shareholders
EUR 1,079,033.50
Unspecified other liabilities
EUR 34,239.63
Guarantees and other commitments
EUR 266,276.80
Liability from creation of a security
interest for third parties
EUR 266,276.80
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code (HGB)
Sales
EUR 17,697,765.37
Other operating income
EUR 1,192,212.74
Cost of materials
EUR 14,619,224.08
Raw materials and supplies, purchased
goods
EUR 14,102,778.60
Purchased services
EUR 516,445.48
Gross result (+/-)
EUR 4,270,754.03
Staff expenses
EUR 1,982,874.23
Wages and salaries
EUR 1,693,712.93
Social security contributions and
expenses for pension plans and
benefits
EUR 289,161.30
Total depreciation
EUR 83,747.28
Depreciation on tangible / intangible
asssets (incl. start-up and exp. of
bus.
EUR 83,747.28
Other operating expenses
EUR 1,214,789.61
Operating result from continuing
operations
EUR 989,342.91
Result from participating interests
(+/-)
EUR 353,512.35
Expenses / income from participations EUR 353,512.35
Income from related companies
EUR 353,512.35
Interest result (+/-)
EUR -92,039.88
Interest and similar income
EUR 37,457.40
Interest and similar expenses
EUR 129,497.28
Financial result (+/-)
EUR 261,472.47
Result from ordinary operations (+/-)
EUR 1,250,815.38
Income tax / refund of income tax (+/-)EUR -252,762.86
Other taxes / refund of taxes
EUR -3,498.21
Tax
(+/-)
EUR -256,261.07
Annual surplus / annual deficit
EUR 994,554.31
Type of balance
sheet: Company balance sheet
Financial year: 01.01.2012 - 31.12.2012
ASSETS EUR 5,582,763.93
Fixed assets
EUR 316,462.88
Intangible assets
EUR 47,190.50
Tangible assets
EUR 126,514.00
Financial assets
EUR 142,758.38
Other / unspecified financial assets EUR 142,758.38
Current assets EUR 5,256,988.88
Stocks
EUR 1,043,662.12
Accounts receivable
EUR 3,262,115.27
Other debtors and assets
EUR 3,262,115.27
Liquid means
EUR 951,211.49
Remaining other assets
EUR 9,312.17
Accruals (assets)
EUR 9,312.17
LIABILITIES EUR 5,582,763.93
Shareholders'
equity EUR 831,120.60
Capital
EUR 400,000.00
Subscribed capital (share capital)
EUR 400,000.00
Balance sheet profit/loss (+/-)
EUR 431,120.60
Balance sheet profit / loss
EUR 431,120.60
Provisions
EUR 966,945.91
Liabilities
EUR 3,784,697.42
Other liabilities
EUR 3,784,697.42
Trade creditors (for IAS incl. bills
of exchange)
EUR 2,381,090.34
Liabilities from received advance
payments
EUR 251,930.00
Liabilities
due to shareholders EUR 1,079,033.50
Unspecified other liabilities
EUR 72,643.58
PROFIT AND LOSS ACCOUNT (cost-summary method)
according to Comm.
Code (HGB)
Sales
EUR 16,502,383.02
Other operating income
EUR 761,083.30
Cost of materials
EUR 13,907,440.52
Raw materials and supplies, purchased
goods
EUR 13,324,603.70
Purchased services
EUR 582,836.82
Gross result (+/-)
EUR 3,356,025.80
Staff expenses
EUR 1,688,449.20
Wages and salaries
EUR 1,425,435.32
Social security contributions and
expenses for pension plans and
benefits
EUR 263,013.88
Total depreciation
EUR 72,703.02
Depreciation on tangible / intangible
asssets (incl. start-up and exp. of
bus.
EUR 72,703.02
Other operating expenses
EUR 1,050,219.60
Operating result from continuing
operations
EUR 544,653.98
Result from participating interests
(+/-)
EUR 45,500.00
Expenses / income from participations EUR 45,500.00
Income from related companies
EUR 45,500.00
Interest result (+/-)
EUR -66,114.33
Interest and similar income
EUR 84,174.10
Interest and similar expenses
EUR 150,288.43
Financial result (+/-)
EUR -20,614.33
Result from ordinary operations (+/-)
EUR 524,039.65
Extraordinary expenses
EUR 5,578.60
Extraordinary result (+/-)
EUR -5,578.60
Income tax / refund of income tax (+/-)EUR -148,499.34
Other taxes / refund of taxes
EUR -4,577.21
Tax
(+/-)
EUR -153,076.55
Annual surplus / annual deficit
EUR 365,384.50
Inconsistent balance sheets:
Financial year published on
01.01.2010 - 31.12.2010 20.12.2011
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.52 |
|
|
1 |
Rs.95.96 |
|
Euro |
1 |
Rs.70.54 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.